Pancreatic Cancer Research

ResearcherKunming Medical UniversityActive in the last 2 years

Dongyun Cun

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5047728339. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 3 papers

Papers 3

  1. METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. Co-author DOI 10.1007/s12672-025-03393-3↗
  2. Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Co-author DOI 10.1016/j.prp.2025.156186↗
  3. O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic ca… Co-author DOI 10.1186/s10020-025-01285-4↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Wei · 2 shared papers, 2025 · strength 0.49
  2. Bo Tang · 2 shared papers, 2025 · strength 0.49
  3. Renchao Zou · 2 shared papers, 2025 · strength 0.49
  4. Tao Wu · 2 shared papers, 2025 · strength 0.49
  5. Peng Chen · 1 shared paper, 2025 · strength 0.30
  6. Qiuhong Wang · 1 shared paper, 2025 · strength 0.26
  7. Qiuhong Wang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.